| FMD | Flow-mediated dilation |
| sFlt1 | Soluble fms-like tyrosine kinase 1 |
| VEGF | Vascular endothelial growth factor |
| PlGF | Placental growth factor |
| sVEGFR1 | Soluble vascular endothelial growth factor receptor 1 |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| PGI2 | Prostacyclin |
| TXA2 | Thromboxane A2 |
| COX | Cyclooxygenase |
| sGC | Soluble guanylate cyclase |
| AC | Adenylyl cyclase |
| ET-1 | Endothelin 1 |
| ECE-1 | Endothelin-converting enzyme 1 |
| aHUS | Atypical hemolytic uremic syndrome |
| IUGR | Intrauterine growth restriction |
| APS | Antiphospholipid syndrome |
| CKD | Chronic kidney disease |
| SLE | Systemic lupus erythematosus |
| PWA | Pulse wave analysis |
| PWV | Pulse wave velocity |
| RNAi | RNA interference |
| MAP | Mean arterial pressure, and |
| UtA-PI | Uterine artery pulsatility index |
| MMPs | Matrix metalloproteinases |
| ECM | Extracellular matrix |
| HIF1α | Hypoxia-inducible factor 1α |